Editorial: Advancements in Molecular Profiling of Thyroid Lesions with Next-Generation Technologies, Volume III

1

Next-generation technologies have transformed the interpretation and management of thyroid lesions, integrating molecular profiles into diagnostics.
2

BRAF alterations are central to papillary thyroid cancer, with studies showing the need for continuous therapeutic modulation beyond target mutation identification.
3

Integration of mutational profiling and pathway analysis enhances prognostic models, emphasizing the functional context of mutations in thyroid cancer.
4

mRNA-expression-based classifiers can predict low risk of lymph node invasion in thyroid cancers, guiding conservative treatment decisions.
5

The thyroglobulin-to-tumor volume ratio improves preoperative diagnosis of follicular neoplasms, highlighting the value of integrating classical biomarkers.

1